- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02031809
Multicentric Study VATS Major Introperative Complications
Analysis of the Most Common Major Intraoperative Complications During Video-assisted Thoracoscopic Surgery (VATS) Anatomical Resections - On Behalf of MITIG-ESTS
Study Overview
Status
Conditions
Detailed Description
Vats lobectomy is becoming the standard of care for early stage lung cancer. Several studies have shown feasibility and safety in dedicated centres. Compared to thoracotomy the procedure results in at least equal oncologic results and survival, perhaps better.
Most series do not publish their early experience. They are retrospective and report on lobectomies and segmentectomies, excluding the live-saving pneumonectomies. They are potentially ignoring the intention-to-treat principle, excluding conversions.
Based on scarce existing literature and conference worst-case presentations a pattern of the most common intraoperative major complications can be drawn In Europe, a large percentage of high-volume-centres have now successfully implemented a vats lobectomy program. In this era with low-volume-centres switching into vats anatomical resections, it is important to focus on potentially life-threatening complications. To be aware of potential hazards is the best way to avoid them.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Innsbruck, Austria
- Department of Visceral, Transplant and Thoracic Surgery, Innsbruck University Hospital
-
-
-
-
-
Copenhagen, Denmark
- Department of cardiothoracic surgery, Rigshospitalet
-
-
-
-
-
Paris, France, F-75014
- Thoracic Department, Institut Mutualiste Montsouris
-
-
-
-
-
Koblenz, Germany
- Katholisches Klinikum, Thoraxchirurgie
-
-
-
-
-
Ancona, Italy, 60020
- Division of Thoracic Surgery, Ospedali Riuniti Ancona
-
-
-
-
-
Heerlen, Netherlands
- Maatschap Heelkunde Zuid-Limburg
-
-
-
-
-
Poznan, Poland
- Karol Marcinkowski University of Med Sciences, Department of Thoracic Surgery
-
-
-
-
-
Coruña, Spain
- Department of Thoracic Surgery
-
-
-
-
-
Zürich, Switzerland
- Universitätsspital Zürich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients that did undergo resection for oncologic reasons
Exclusion Criteria:
- Patients that did not undergo resection for oncologic reasons, such as pleural metastasis, irresectable disease.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
|---|
|
No additional unplanned major surgery
uneventfull intra-operative and postoperative course
|
|
Additional unplanned major surgery
Additional per-operative or post-operative unplanned major surgery such as unforeseen pneumonectomy, bilobectomy, lobectomy or additional segmentectomy, repair of major vessels or bronchi, bronchopleural fistula, unplanned surgery to other organs, within 30 days after the primary surgery. These do not include:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
additional unplanned major surgery
Time Frame: during vats anatomical resection or at revision within 30 days
|
the percentage of major complications that resulted in additional unplanned major surgery during vats anatomical resection or at revision within 30 days.
|
during vats anatomical resection or at revision within 30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of conversions to open surgery
Time Frame: during VATS procedure
|
The number of VATS procedures that need conversion to open surgery because of major complications or unplanned major surgery
|
during VATS procedure
|
Collaborators and Investigators
Investigators
- Principal Investigator: Herbert Dacaluwé, MD, Universitaire Ziekenhuizen KU Leuven
- Principal Investigator: Dominique Gossot, MD, Thoracic Department, Institut Mutualiste Montsouris, 42 Bd Jourdan, F-75014 Paris, France
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MC_VATS complic
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.